Target intelligence / Profile preview

CCNQ pseudogene 3 (CCNQP3)

Target
CCNQP3
Molecular classification
Pseudogene, Non-coding RNA (lncRNA family member; inferred based on general pseudogene biology[2][5])
01

Overview

CCNQ pseudogene 3 is annotated as a pseudogene locus in the human genome. Pseudogenes are generally non-protein-coding genetic elements that resemble known genes but contain sequence disablements such as premature stop codons or frameshifts[4]. While traditionally considered non-functional, recent studies reveal that some pseudogenes can play regulatory roles by acting as competitive endogenous RNAs (ceRNAs), modulating gene expression through microRNA decoy activity[1][2][5]. However, there is no direct evidence that CCNQ pseudogene 3 encodes any functional RNA or modulates biological pathways or disease processes. It is not considered a receptor, enzyme, transporter, or pharmacological target[3]. CCNQP3 has no reported disease associations, interacting drugs, or biomarker status. This entry is considered incorrect as a druggable target: while pseudogenes can have regulatory function via ceRNA networks, CCNQP3 itself is not an established functional pseudogene, nor is it therapeutically actionable[3].

Other names
CCNQP3
02

Biological functions

Competitive endogenous RNA (ceRNA) activity via microRNA sponge action (inferred by analogy to other pseudogenes[2][5])Gene expression modulation through ceRNA networks (supported for the pseudogene class[2][5])Other (no specific, experimentally validated molecular function for CCNQP3[3])
03

Disease associations

Other (no specific disease association for CCNQP3, though other pseudogenes can influence tumorigenesis through ceRNA mechanisms[2][5])

Beyond the preview

Go deeper on CCNQ pseudogene 3 (CCNQP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCNQ pseudogene 3 (CCNQP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call